What were Gilead's main financial results for Q3 2021?

The 8-K filing announces Gilead's Q3 2021 financial results, which are detailed in the accompanying press release (Exhibit 99.1). While the 8-K itself doesn't list specific figures, it directs investors to the press release for comprehensive GAAP and non-GAAP financial data, including revenue, earnings, and other key performance indicators for the quarter ended September 30, 2021.

Why is Gilead redeeming $1 billion of its 2023 Notes?

Gilead is redeeming both its Floating Rate Senior Notes due 2023 and its 0.750% Senior Notes due 2023, for a total principal amount of $1 billion. While the specific strategic reasons are not detailed in the 8-K, this action often indicates a company's effort to manage its debt obligations, optimize its capital structure, take advantage of lower interest rates for refinancing, or reallocate capital.

What is the redemption price for the 2023 Notes?

The redemption price for the 2023 Notes will be 100% of the principal amount being redeemed, plus any accrued and unpaid interest from September 29, 2021, up to, but not including, the redemption date of November 8, 2021.

Are the non-GAAP financial measures presented by Gilead directly comparable to other companies?

Gilead states that non-GAAP information is provided to supplement understanding and is used internally for operational, budgeting, and financial planning. They caution that non-GAAP measures are not prepared under comprehensive accounting rules and may be defined and calculated differently by other companies in the same industry. Investors should refer to the reconciliation provided in the press release for a clear comparison between GAAP and non-GAAP figures.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on October 28, 2021, primarily to announce its third-quarter 2021 financial results via a press release. The report details both GAAP and non-GAAP financial figures, emphasizing that non-GAAP measures are provided to supplement understanding and are used internally for operational and planning purposes. Investors are encouraged to review the reconciliation tables within the press release for a full comparison. Beyond the quarterly results, the filing also discloses Gilead's decision to redeem its Floating Rate Senior Notes due 2023 and 0.750% Senior Notes due 2023, totaling $1 billion in aggregate principal. The redemption is scheduled for November 8, 2021, and will occur at 100% of the principal amount plus accrued interest. This action indicates a potential move to optimize the company's capital structure or manage its debt.

Key Highlights

1Gilead Sciences announced its Q3 2021 financial results via a press release included in the 8-K filing.
2The company provided both GAAP and non-GAAP financial information, with a focus on management's internal use of non-GAAP metrics.
3A reconciliation between GAAP and non-GAAP figures is available in the press release for investor review.
4Gilead is redeeming $500 million of Floating Rate Senior Notes due 2023.
5Gilead is also redeeming $500 million of 0.750% Senior Notes due 2023.
6The combined redemption of these 2023 Notes totals $1 billion.
7The redemption date for these notes is November 8, 2021.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Oct 28, 2021)

Summary

Key Highlights

Frequently Asked Questions